A Study to Evaluate the Efficacy and Safety of LZM012
Clinical trial NCT06110676 · UNKNOWN
Trial details
- NCT number
- NCT06110676
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-21
- Primary completion
- 2025-04-01
- Enrollment
- 918
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.